Clinical Trials in Nashville

Showing 6561-6580 of 20,298 trials

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

This is a first-in-human open-label Phase 1/2a study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of 23ME-00610 given by intravenous infusion in patients with advanced solid malignancies who have progressed on all available standard therapies

Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more

23andMe, Inc.141 participantsStarted Dec 2021

Palo Alto, California, United States • Atlanta, Georgia, United States • Detroit, Michigan, United States +10 more locations

Active Not RecruitingNA< 1 mile

Expanding Rural Health Cancer Control Capacity

NCT04765072

Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.

Cancer

Debra Friedman33 participantsStarted Feb 2021

Columbus, Mississippi, United States • Oxford, Mississippi, United States • Bartlett, Tennessee, United States +1 more locations

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Expanding Rural Health Cancer Control Capacity

Find Trials by Condition in Nashville

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

Social Needs App for Oncology Patients Phase II

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Pediatric Adenotonsillectomy Trial for Snoring

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers